Pharmacy Times

JULY 7, 2025

million global deaths recorded in 2017. Updated October 16, 2017. The data, which were published in Nephrology , also highlighted comparable safety among the 2 treatments. The global prevalence is estimated to be about 11% to 13%, with 697.5 million cases of all-stage disease CKD and 1.2 ClinicalTrials.gov identifier: NCT02044653.

Compounding Pharmacies

Pharmacy Times

JULY 8, 2025

Anti-TNFs remain the only FDA-approved class for pediatric IBD, prompting biosimilar use for cost and accessibility. The study found no significant differences in biosimilar use by age, race, or ethnicity, but regional variations existed.

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 20, 2025

Updated July 14, 2017. If the bites worsen or signs of infection develop, if symptoms persist beyond a week, or if there are concerns about allergic reactions or fevers, he may need to visit a health care provider. 6 REFERENCES 1. Sun protection factor (SPF). Accessed May 12, 2025. Sunburn: treatment and prevention. Healthchildren.org.

Compounding Pharmacies

Pharmacy Times

AUGUST 7, 2025

4 These findings led to the 2017 FDA approval of CPX-351 for adult patients with t-AML or AML-MRC. However, the efficacy and safety of CPX-351 in adults younger than 60 years is not well established.

Chemotherapy

The Checkup by Singlecare

DECEMBER 28, 2023

Although Ozempic has been approved by the Food and Drug Administration (FDA) since 2017, its status as a household name is relatively recent. Weight loss is an off-label , non-FDA-approved use for Ozempic. The FDA has urged consumers to use caution when taking medication from these compound pharmacies.

Insurance

ISPE

MARCH 8, 2023

Identification and Analysis of Contamination Trends Three major recall databases—those of the US FDA, the United Kingdom’s Medicine and Healthcare Products Regulatory Agency (UK MHRA), and Australia’s Therapeutic Goods Administration (TGA)—were searched to assess contamination trends in the past five years.

Compounding

The Thyroid Pharmacist

MAY 19, 2023

Naltrexone is an FDA-approved medication used for opioid withdrawal at a dose of 50 mg per day. 20] This medication is available only as a prescription and can be compounded into lower doses by special professional compounding pharmacies. October 4, 2017. Low-dose naltrexone can be helpful for Hashimoto’s.

Immunization

The Checkup by Singlecare

APRIL 22, 2025

Ozempic was approved by the Food and Drug Administration (FDA) in 2017 for the treatment of Type 2 diabetes. In 2020, the FDA approved Ozempic for reducing the risk of heart attack, stroke, or death in adults with Type 2 diabetes with known heart disease. FDA , 2025) How much do Americans spend on Ozempic?

Compounding

The Thyroid Pharmacist

NOVEMBER 15, 2024

17] Ozempic is a once-weekly injection that was approved by the FDA in 2017 for use in adults with type 2 diabetes. Compounding pharmacies will sometimes repackage these drugs, or create lower or different concentrations than what’s typically available. 2017 Jan;176(1):11-19. Published 2017 Feb 3.

Immunization